Mörttinen-Vallius, Heidi http://orcid.org/0000-0001-8164-1173
Hartikainen, Sirpa
Seinelä, Lauri
Jämsen, Esa
Funding for this research was provided by:
Suomen Lääketieteen Säätiö
Competitive State Research Financing (9U068)
Article History
Received: 4 April 2020
Accepted: 4 June 2020
First Online: 29 June 2020
Compliance with ethical standards
:
: HMV has received a research grant from the Finnish Medical Foundation. SH has received a lecture fee (unrelated to the present study) from Astellas. LS declares he has no conflict of interest. EJ has received lecture fees (unrelated to the present study) from Novartis, Orion Pharma, and Finnish societies of medical professionals.
: This research study was conducted retrospectively from data obtained for clinical purposes. Persons in this study were not contacted, and as the retrospective study protocol did not have an effect on their treatment, neither ethics board approval nor informed patient consent was required by Finnish law.
: For this type of study, formal consent is not required.